Table 22. [Characteristics of GLP-1 Receptor Agonist Pen Devices]. - Endotext

Generic	Exenatide	Exenatide	Exenatide	Lixisenatide	Liraglutide	Dulaglutide	Semaglutide
Single or multiple use	Multiple	Single	Single	Multiple	Multiple	Single	Multiple
Dose*	5 or 10ug	2mg	2mg	10 or 20ug	0.6, 1.2, or 1.8mg	0.75 or 1.5mg	0.25, 0.5, or 1.0mg
Preparation	None	Resuspend	Mix	None	None	None	None

Endotext [Internet].

Feingold KR, Anawalt B, Blackman MR, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

This electronic version has been made freely available under a Creative Commons (CC-BY-NC-ND) license. A copy of the license can be viewed at http://creativecommons.org/licenses/by-nc-nd/2.0/.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Generic	Exenatide	Exenatide	Exenatide	Lixisenatide	Liraglutide	Dulaglutide	Semaglutide
Brand	Byetta	Bydureon	Bydureon BCise	Lyxumia	Victoza	Trulicity	Ozempic
Single or multiple use	Multiple	Single	Single	Multiple	Multiple	Single	Multiple
Dose*	5 or 10ug	2mg	2mg	10 or 20ug	0.6, 1.2, or 1.8mg	0.75 or 1.5mg	0.25, 0.5, or 1.0mg
Preparation	None	Resuspend	Mix	None	None	None	None